ACE and hydrops fetalis: During the study period, HF patients received Angiotensin-converting enzyme inhibitors 56 (21.0%), angiotensin receptor blockers 66 (24.8%), spironolactone 103 (38.7%), furosemide 159 (59.8%), and digoxin 33 (12.4%).